Endocardial launches cardiac system in Europe:
This article was originally published in Clinica
Medtronic is to begin European distribution of Endocardial Solutions' cardiac diagnostic product, the EnSite 3000 System, and the EnSite catheter. St Paul, Minnesota-based Endocardial's system provides a 3D graphical display of the heart's electrical activity to diagnose arrhythmias in patients who cannot be fully evaluated using existing methods. Medtronic maintains the combination of the mapping technology together with its own ablation technology and distribution network has "excellent potential" in Europe.
You may also be interested in...
With its US/Mexico Phase III trial delayed due to manufacturing questions, Novavax has aligned its UK study with FDA guidance. It hopes for interim data from that study during Q1 2021.
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.
The guidance document allows manufacturers to promote their dry-heat systems for mask bioburden reduction if they meet certain standards.